Why it matters nowThe findings indicate that subnational variation in net use after access may be relevant when considering malaria-control deployment strategies. The abstract describes a framework for using routinely collected data to support subnational programme tailoring.
Why it matters nowThe MTB-HR assay did not meet WHO target product profile criteria for screening or prognostic use, but its positive predictive value exceeded that of currently used tests. The authors suggest the assay may still have a role in tuberculosis screening and prevention strategies for household contacts, a priority population where existing tests perform poorly.
Why it matters nowThe paper presents TB screening as a possible point to find and address other health problems in affected households. It frames integrated approaches as a way to identify people at higher risk and connect them with preventive or treatment services.
Why it matters nowThe work addresses diarrheal disease, cited as one of the top two causes of young child mortality in the developing world, and aims to inform prioritization of water/sanitation, hygiene, and vaccine strategies.
Why it matters nowThe paper is relevant to malaria prevention in infants and to economic evaluation of a preventive intervention delivered through routine immunization services. It may help readers compare value-for-money estimates across program settings.